CYP2D6 Substrate Dispensing Among Patients Dispensed Mirabegron: An Administrative Claims Analysis

BACKGROUND: Overactive bladder (OAB) is characterized by the presence of bothersome urinary symptoms. Pharmacologic treatment options for OAB include anticholinergics and β(3)-adrenergic agonists. Use of β(3)-adrenergic agonists may result in similar treatment efficacy with a decreased side effect p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritchey, Mary E., Wang, Jingjun, Young, Jessica C., Chandra, Rajat, Carrera, Adam, Goti, Noelia, Horn, John R., Girman, Cynthia J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944153/
https://www.ncbi.nlm.nih.gov/pubmed/36456851
http://dx.doi.org/10.1007/s40801-022-00339-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944153/
https://www.ncbi.nlm.nih.gov/pubmed/36456851
http://dx.doi.org/10.1007/s40801-022-00339-x

Ejemplares similares